Back
Speaker illustration

Doctor Puriya Daniel Wuertz Yazdanfard

Nordsjaellands Hospital, Hilleroed (Denmark)

Member of:

European Society of Cardiology

Presentations

Sodium-Glucose Co-Transporter 2 inhibitors and cardiovascular outcomes: a trial-similar population vs. a broad population

Event: ESC Congress 2025

Topic: Antidiabetic Pharmacotherapy

Session: What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?

Access
Like
Thumbnail

All cause mortality in people with type 2 diabetes using SGLT-2 inhibitors compared to DPP4 inhibitors using the danish registries

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session: Real-world evidence on the cardiovascular effects of therapies for diabetes

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources